IGF1 and colon adenocarcinoma: Among these 9 candidate targets, AGT, DRD2, IL-1B, and IL-6 were significantly increased in primary tumor compared with the normal tissues, while ALB, IL-10, and IGF1 were significantly decreased in COAD tissues.